cTnI 2 plus 2 concept, the precise immunoassay 09-06-07

We are proud to present our new concept for the development of cTnI assays. We call this approach as “2+2 concept”. Such assay would be cardiac specific and almost insensitive to all known factors that could affect cTnI measurements. We can suggest several combinations of monoclonal antibodies useful according to 2+2 concept. Please find more information from our “cTnI 2+2 concept” TechNotes.  

Kauppalehti AchievementISO 9001